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Summary and Implications 
 Horses were inoculated with several strains of 
virulent PRRS virus.  Sera from the horses were tested for 
the presence of PRRS virus-neutralizing antibodies.  
Large volumes of equine plasma were collected and used 
to passively immunize piglets.  Sera were collected at 
various time points after immunization and tested for 
virus-neutralizing activity. 
These results show that horses are capable of generating 
high neutralizing antibody titers to PRRSV when exposed 
to virulent virus.  Piglets develop neutralizing antibody 
titers to PRRSV when passively immunized with a 
sufficient volume of ά-PRRSV equine plasma. 
 
Introduction 
 Previous studies have indicated that passive 
immunization of pigs with hyperimmune swine plasma 
can confer complete or partial protection to virulent 
PRRSV challenge, as determined by clinical signs and 
viremia.  While horses historically have been used to raise 
large volumes of antibody to different organisms and 
toxins, there is currently no published data regarding the 
inoculation of horses with live PRRSV.  The objective of 
our research was to produce high-titer antiserum in horses 
which could be used to passively immunize pigs for the 
prevention of PRRS clinical signs and viremia. 
 
Materials and Methods 
 
Immunization of Horses with PRRSV 
 Each horse received a total of five intramuscular 
injections of virulent PRRSV.  The same strain was used 
in the first two injections, while three different strains 
were used for subsequent injections.  Each inoculation 
consisted of a 10 ml volume split between three injection 
sites.  All strains were sequenced and titrated at 105 
TCID-50 per ml.  Horses were inoculated on Days 0, 21, 
41, 84, and 126, and study termination occurred on Day 
137. 
 
Concentration of Equine Plasma 
 Plasma collected at study termination was put into 
lengths of dialysis tubing (12-14,000 MWCO) and 
covered with 40,000 MW polyethylene glycol.  After 3.75 
hours the concentrated plasma was collected and 
combined with raw plasma, resulting in a final 
concentration of 3.8x.  The same procedure was used on 
normal horse plasma.  All plasma was sterilized through 
0.45 μm filters. 
 
Passive Immunization Studies 
 Study I utilized filter-sterilized equine plasma 
(normal and ά-PRRSV).  Eight pigs were each injected 
(sub-Q) with 80 ml of ά-PRRSV equine plasma, and four 
pigs were each injected (sub-Q) with 80 ml of normal 
equine plasma.  Blood was collected at various times 
following immunization and tested to determine 
circulating virus-neutralizing antibody (FFN) titers. 
 Study II utilized the concentrated equine plasma 
(normal and ά-PRRSV).  Six pigs received concentrated 
ά-PRRSV plasma at a rate of 10 ml per kg bodyweight.  
Two pigs received a dose of 5 ml per kg bodyweight.  
Four pigs received concentrated normal equine plasma at 
a rate of 7.5 ml per kg bodyweight.  Blood collection and 
testing methods were the same as Study I. 
 
Results 
 
Immunization of Horses with PRRSV 
 Horses did not become febrile or show any clinical 
signs of disease throughout the study.  No injection site 
reactions were observed.  No detectable virus was present 
in serum when tested on MARC-145 cells. 
Both horses had an initial FFN titer of <1:4 against the 
first strain used.  At study termination on Day 137, the 
horses had a geometric mean FFN titer of 1:181 against 
the first strain used.  The geometric mean FFN titers 
against the 3rd and 4th strains used were 1:128 and 1:90 
respectively.   
 These results are detailed in Figure 1. 
 
Concentration of Equine Plasma 
 The ά-PRRSV equine plasma used in the 
concentration procedure had a beginning FFN titer of 
1:256.  Following concentration to 3.8x the FFN titer 
increased to 1:1024. The normal equine plasma used in 
the concentration procedure had a beginning titer of <1:4.  
Following concentration to 3.4x the FFN titer increased to 
1:8. 
 These results are detailed in Figure 2. 
 
Passive Immunization Studies 
 In Study I, piglets (n=8) that received ά-PRRSV 
equine plasma had a geometric mean FFN titer of 1:6 at 
24 hours post immunization.  Piglets (n=8) that received 
normal equine plasma had a geometric mean FFN titer of 
<1:4 at 24 hours post immunization. 
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 In Study II, piglets (n=2) that received concentrated 
ά-PRRSV equine plasma at a rate of 5 ml/kg had a 
geometric mean FFN titer of 1:16 at 24 hours post 
immunization.  Piglets (n=6) that received the same 
plasma at a rate of 10 ml/kg had a geometric mean FFN 
titer of 1:25 at 24 hours post immunization.  Piglets (n=4) 
that received concentrated normal equine plasma at a rate 
of 7.5 ml/kg had a geometric mean FFN titer of <1:4 at 24 
hours post immunization. 
 Results of passive immunization studies are detailed 
in Figure 3. 
 
Discussion 
 These results indicate that horses are capable of 
generating relatively high virus-neutralizing antibody 
titers when immunized with virulent PRRS virus.  Equine 
plasma can be concentrated and used to passively 
immunize piglets, which results in circulating virus-
neutralizing antibody titers at 24 hours post-
immunization. 
 
 One benefit of using equine plasma is the 
comparatively large volume of plasma that can be 
recovered from a single animal.  Another benefit is that 
the current PRRS ELISA diagnostic test is specific to 
porcine ά-PRRSV antibodies, which allows piglets 
immunized with equine plasma to still show a negative 
IDEXX PRRS ELISA result.  In this way, the IDEXX 
PRRS ELISA can be used to determine viral exposure in 
pigs that receive passively administered equine 
antibodies. 
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Strain Mean FFN Titer Horse #1 FFN Titer Horse #2 FFN Titer 
1st 1:181 1:128 1:256 
2nd ND ND ND 
3rd 1:128 1:64 1:256 
4th 1:90 1:64 1:128 
Figure 1. FFN titers (Day 137) to strains of PRRSV used in the immunization of horses. 
 
 
 Not concentrated 
(Study I) 
Concentrated 
(Study II) 
ά-PRRSV equine plasma 1:256 1:1024 
Normal equine plasma <1:4 1:8 
Figure 2. FFN titers (1st strain) of equine plasma used to passively immunize piglets. 
 
 
Study Dosage 
Rate 
Type of Plasma Mean FFN Titer 
@ 24 hr post imm. 
I 80 ml/pig ά-PRRSV 1:6 
I 80 ml/pig normal <1:4 
II 5 ml/kg Conc. ά-PRRSV 1:16 
II 10 ml/kg Conc. ά-PRRSV 1:25 
II 7.5 ml/kg Conc. normal <1:4 
Figure 3. FFN titers (1st strain) at 24 hours post-immunization of piglets receiving different types and dosages of 
plasma in passive immunization studies. 
